Evidence map›Paper›PMID 41972240›Full record

ArticleEuropean heart journal. Case reports2026

Intracardiac paraganglioma in the left atrium in the context of a hereditary syndrome due to SDHD mutation: a case report.

Pablo Rojas-Romero, Jaime Nevado-Portero, Francisco Javier Ruperti-Repilado, Mariano García-de-la-Borbolla-Fernández, José Eduardo López-Haldón

Abstract readCase Reports
In one paragraph

Article in European heart journal. Case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Pablo Rojas-RomeroCardiology Service, University Hospital Virgen del Rocio, Avenida Manuel Siurot s/n, Seville 41013, Spain.ORCID https://orcid.org/0009-0007-0865-4286
Jaime Nevado-PorteroCardiology Service, University Hospital Virgen del Rocio, Avenida Manuel Siurot s/n, Seville 41013, Spain.
Francisco Javier Ruperti-RepiladoAdult Congenital Heart Disease Unit, Department of Cardiology, University Hospital Virgen del Rocio, Avenida Manuel Siurot s/n, Seville 41013, Spain.
Mariano García-de-la-Borbolla-FernándezCardiovascular Surgery Service, University Hospital Virgen del Rocio, Avenida Manuel Siurot s/n, Seville 41013, Spain.ORCID https://orcid.org/0009-0003-0986-9853
José Eduardo López-HaldónCardiology Service, University Hospital Virgen del Rocio, Avenida Manuel Siurot s/n, Seville 41013, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Cardiac paragangliomas are extremely rare, accounting for less than 0.3% of cardiac tumours. Their management may become a clinical challenge. Case summary: We present a case of a woman with an adrenergic crisis due to a cardiac paraganglioma in the context of a familial inherited paraganglioma syndrome. For the diagnosis, it was necessary to integrate different imaging techniques, such as echocardiogram, MRI, or PET-CT. A percutaneous embolization of the tumour and an adrenergic pharmacological blockade for a successful surgery was made. Discussion: This case shows the importance of the use of different imaging techniques for the diagnosis of cardiac tumours, integrating MRI with nuclear medicine functional test. Due to the high haemorrhagic risk of cardiac paragangliomas, a percutaneous embolization prior to surgery was carried out to avoid haemorrhagic complications. The cardiac location of paragangliomas is highly related with inherited familiar syndromes.

Indexed as

Cardiac imaging techniquesCardiac paragangliomaCase ReportPercutaneous EmbolizationSDHD Syndrome

Identifiers

PMID41972240
PMCPMC13064498

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.